Drug Pipeline

Vistusertib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT02813135 European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in… Pediatric Cancer Recruiting
Phase 1
NCT02546661 Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle… Muscle Invasive Bladder Cancer Active, Not Recruiting
NCT02208375 mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial… BRCA1 Mutation Carrier Active, Not Recruiting
Sponsors Running Vistusertib Trials
M.D. Anderson Cancer Center (1) AstraZeneca (1) Gustave Roussy, Cancer Campus, Grand Paris (1)
Disease Areas
Breast Cancer (1) Ovarian Cancer (1) Bladder Cancer (1)
Get alerts when Vistusertib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free